Illumina Inc

Healthcare · Diagnostics & Research

273.90$ +7.3% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

Illumina Inc (ILMN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 1,159 million $. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

Tick rows to compare them in a chart (up to 4)

Income Statement ILMN
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	607	619	598	662	714	778	782	830	853	867	846	838	907	952	859	633	794	953	1,093	1,126	1,108	1,199	1,223	1,162	1,115	1,084	1,087	1,176	1,119	1,122	1,076	1,112	1,080	1,104	1,041	1,057	1,083	1,160	1,091	1,159	4,493
Cost of Revenue	181	200	230	228	232	235	244	255	256	277	262	265	259	290	240	205	268	323	329	324	338	382	408	395	398	411	432	444	435	448	409	391	335	376	356	340	351	382	370	389	1,492
Gross Profit	426	419	368	434	482	542	538	575	597	590	584	573	648	662	619	428	526	630	764	802	770	817	815	767	717	672	655	732	684	674	667	721	745	728	685	717	732	778	721	770	3,001
Research & Development	126	130	145	130	134	137	137	151	159	176	169	166	151	161	156	155	172	199	197	202	436	350	323	327	325	346	341	358	315	341	338	325	253	255	241	243	228	238	240	252	958
Selling, General & Administrative	139	146	163	169	167	175	183	197	197	217	211	202	189	233	274	177	192	941	374	413	879	426	308	410	146	432	378	450	303	485	439	147	239	279	267	241	277	283	272	273	1,105
Total Operating Expenses	265	276	316	291	301	312	320	348	356	393	380	368	340	394	430	332	364	497	571	615	1,315	776	631	1,346	4,374	800	719	820	1,438	838	778	2,358	4.0	526	501	495	501	521	512	525	2,059
Operating Income	161	143	52	143	181	230	218	227	241	197	204	205	308	268	189	96	162	133	193	187	-545	42	184	-579	-3,657	-127	-64	-88	-754	-164	-111	-1,637	741	202	184	222	231	257	209	245	942
Interest Expense	9.0	8.3	8.0	8.0	10	11	11	11	15	20	15	15	11	11	11	11	11	16	19	16	14	13	6.0	6.0	6.0	8.0	20	19	19	18	18	20	36	25	25	25	25	26	24	–	–
Pre-Tax Income	154	134	503	141	175	223	221	232	232	209	233	346	270	269	178	165	215	299	169	207	420	86	140	-637	-3,672	-168	-78	-89	-782	-167	-109	-1,976	720	188	182	306	220	378	157	260	1,015
Income Tax Expense	37	27	155	21	23	166	24	32	44	12	9.0	53	36	30	5.0	118	36	42	22	22	103	-26	54	-102	144	28	-81	145	-28	8.0	17	12	15	1.0	51	71	70	44	23	53	190
Net Income	129	124	373	128	163	68	208	209	199	210	233	296	234	239	173	47	179	257	147	185	317	112	86	-535	-3,816	-140	3.0	-234	-754	-175	-126	-1,988	705	187	131	235	150	334	134	207	825
EBITDA	199	180	549	187	226	273	271	288	292	279	295	410	328	325	233	222	273	365	236	272	499	188	237	-537	-3,563	2.0	49	38	-655	-40	17	-1,851	826	283	276	399	312	471	250	330	1,363

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings